Digital Look

Welcome to Digital Look++,
you are not logged in

Deltex Medical Group (DEMG)

Health Care

0.13p

Deltex Medical manufactures and markets TrueVue™ haemodynamic monitoring systems with Oesophageal Doppler Monitoring (ODM™) technology.

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	4.26	(0.21)	(0.03)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	2.40	(0.79)	(0.15)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	2.26	(0.98)	(0.17)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	2.48	(1.15)	(0.17)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	1.78	(1.28)	(0.11)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Holding(s) in Company	08-Apr-2024	17:03	RNS
Posting of Annual Report & Notice of AGM	08-Apr-2024	07:00	RNS
Results for the year ended 31 December 2023	28-Mar-2024	07:00	RNS

Deltex Medical trading well, announces board cha...	04-Dec-2023	ShareCast
Deltex launches new system in UK, EU markets	10-Jul-2023	ShareCast
Revenue falls, cash position shrinks for Deltex ...	06-Jul-2023	ShareCast

28-Jan-2007

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.